StonvexLoading…
StonvexStonvexStonvexCore line items from FRHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-03-31 | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $97.45M | $40.10M | $21.58M | $0.00 |
Operating Income | $225.97M | $104.58M | $438.94M | $235.94M |
Net Income | $153.33M | $76.29M | $379.11M | $205.14M |
EPS (Diluted) | $2.51 | $1.26 | $6.39 | $3.45 |
Total Assets | $13.16B | $9.92B | $8.30B | $5.08B |
Total Liabilities | $11.67B | $8.69B | $7.13B | $4.31B |
Cash & Equivalents | $966.12M | $837.30M | $545.08M | $581.42M |
Free Cash Flow OCF − CapEx | $-13.54M | $1.60B | $-1.10B | $-990.23M |
Shares Outstanding | 61.29M | 60.99M | 60.32M | 59.66M |